Agoracom Blog Home

Author Archive

#Esports gambling revenue set to double this year, research finds SPONSOR: Esports Entertainment Group $GMBL $TECHF $ATVI $TTWO $GAME $EPY.ca $FDM.ca $TNA.ca

Posted by AGORACOM-JC at 3:43 PM on Friday, April 17th, 2020

OUR FEATURED SPONSOR:

GMBL: NASDAQ

WHAT YOU NEED TO KNOW

  • Uplisted to NASDAQ
  • Closed $8.4M public offering
  • Partnered with 190 esports teams
  • Partnered with 250+ esports streamers
  • Launched VIE.gg P2P esports betting platform
  • P2P means an esports fan always wins
  • Superior to “House” model where fans VS. casino
  • Traditional sports teams owners are investing
  • Athletes and celebrities are investing
  • Wall Street is investing
  • Biggest paradigm shift ever seen on the internet

Hub On AGORACOM

————————————–

Esports gambling revenue set to double this year, research finds

30% of current esports gamblers have started within the last month

  • Research from global consumer research agency 2CV and market researcher ProdegeMR has revealed that esports gambling revenue is set to double from $7 billion in 2019 to $14 billion worldwide in 2020 as gamblers seek new alternatives for betting during the sporting events shutdown due to the Covid-19 crisis.

The firms’ survey of 1,028 gamblers aged 18-64 looked at how the pandemic has impacted the gambling climate and the role esports can play in driving revenues for the industry, as reported by SportBusiness.

59% of gamblers have reduced spend on gambling, with 32% having actively looked for new things to bet on and 24% having shifted their focus to other forms of gambling. Also, 69% of respondents said that they had reduced spending on sports gambling, with over half (54%) having stopped spending on sports gambling altogether.

The survey found that 36% of gamblers have bet on esports in the last three months, with 30% of consumers who are betting on esports having only started doing so within the last month. The research also found that 22% of gamblers who have not previously tried betting on esports will consider betting on esports within the next three months, with football, motorsports and tennis proving to be the most popular choices.

62% of respondents said that they needed more information on the sector before gambling on esports. 45% said that esports did not have enough sports-based games, while the same percentage also cited the “assumption that they were more inclined to being fixed” as a reason for avoiding esports betting. Other reasons given for not betting on esports included the assumption that they are less regulated than other sports, that they are two complicated and that it is “too geeky.”

Martin Bradley, research director in technology and entertainment at 2CV, said: “By 2022, the number of esports viewers is estimated to rise to 644 million worldwide, this is up from 454 million viewers in 2019. The Covid-19 pandemic has led to many forms of sports associated with gambling being cancelled or postponed but is also a big opportunity for esports to get in front of this audience.”

“Short-term growth is likely to come from sport-based games, but there are huge opportunities to make this more long-term, as long as consumers are educated properly on esports and what it can offer, as well as considering which kinds of events are best suited to a particular audience,” Bradley concluded.

Source: https://www.yogonet.com/international/noticias/2020/04/17/52967-esports-gambling-revenue-set-to-double-this-year-research-finds

REMINDER: You’re Invited – KABN Systems North America Online “Ask Me Anything” Event Today at 12pm EST

Posted by AGORACOM-JC at 9:14 AM on Friday, April 17th, 2020

KABN Systems North America is in the business of verifying, managing and monetizing online Digital Identity.We’re inviting you to join our online “Ask Me Anything” event with the KABN Systems North America Team

Join Us:

Today from 12pm to 1pm Eastern

Digital Data is the new “Gold”!

KABN North America empowers users to verify, protect, manage and profit from their Digital Identity.  With the recent changes to working, shopping, educating and playing from home, online usage and engagement is growing.

KABN’s business is:

  • About providing consumers with no-cost tools to manage their Digital Identity and profit from the public data.
  • Focused online making us Covid-19 resistant.
  • Relevant to 100% of the online, digital market.
  • Optimized for commercial partnerships in Financial Services, eCommerce, Education, Government, Healthcare, Technology, Gaming & more.
  • Built, scalable, proven and in market today.
  • Aligned with online revenue trends.
  • Run by a veteran team of successful industry leaders.
  • In process of a proposed RTO transaction for public listing.

KABN Systems North America Inc.

www.kabnsystemsna.com

Graph Blockchain $GBLC.ca Applauds Shareholder #Datametrex AI Limited $DM.ca for Their Response to the #Covid19 Pandemic

Posted by AGORACOM-JC at 8:56 AM on Friday, April 17th, 2020
  • President & COO, Christian Scovenna added: “On behalf of the executive team and our Board of Directors of the company, we commend and applaud our minority shareholder Datametrex and their entire team for securing the rights globally to import COVID-19 test kits.
  • For many businesses and sectors facing unprecedent times, Datametrex has stepped up as a business leader in helping Canadians during this crisis.”

Toronto, Ontario–(April 17, 2020) – Graph Blockchain Inc. (CSE: GBLC) (“Graph” or “Company“) applauds Datametrex Limited (TSXV: DM) (FSE: D4G) (minority interest shareholder of 26% of the Company) for securing the rights to import COVID-19 detection kit into Canada and other countries around the globe. See Press Release dated April 16, 2020 Health Canada must approve these COVID-19 test kits before they can be used in Canada. Datametrex is currently working with Health Canada to have the approval of these kits fast-tracked.

President & COO, Christian Scovenna added: “On behalf of the executive team and our Board of Directors of the company, we commend and applaud our minority shareholder Datametrex and their entire team for securing the rights globally to import COVID-19 test kits. For many businesses and sectors facing unprecedent times, Datametrex has stepped up as a business leader in helping Canadians during this crisis.”

“We strongly believe these kits will assist Canada in slowing the spread of COVID-19 and ultimately save lives. It’s incredibly rewarding for us to be able to help Canada combat the spread of COVID-19,” said Andrew Ryu, chairman of the company.

These test kits are currently in use in some European and Asian countries outside of South Korea. Approval work has commenced with the Food and Drug Administration (FDA) in the United States to obtain FDA approval and to authorize the tests under the emergency use authorization program run by U.S. Center for Disease Control (CDC).

The Company will be updating the market and its shareholders over the next week(s) with a corporate update.

The Company is not making any express or implied claims that it has the ability to treat the Covid-19 virus at this time.

About Graph Blockchain Inc.

The Company develops leading-edge private blockchain business intelligence and data management solutions that it will implement into a blockchain supported e-commerce marketplace for the sale of psychedelic and ancillary products in legal jurisdictions.

Additional Information on the Company is available at: www.graphblockchain.com

About Datametrex AI Limited.

Datametrex AI Limited is a technology-focused company with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com).

Additional information on Datametrex is available at www.datametrex.com

For further information, please contact:

Govinda Butcher – CEO
Phone: (416) 522-6688
Email: [email protected]

OR

Christian Scovenna – President & COO
Phone: (416) 453-4708
Email: [email protected]

Forward Looking Statements

This news release contains “forward-looking statements” within the meaning of applicable securities laws. All statements contained herein that are not clearly historical in nature may constitute forward-looking statements. In some cases, forward-looking statements can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy. Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking statements. Such statements may prove to be incorrect and actual results may differ materially from those anticipated.

Forward-looking statements contained in this news release are expressly qualified by this cautionary statement and reflect the Company’s expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/54559

Empower Clinics $CBDT.ca Announces Closing of Private Placement the Launch of Immune System Tele-Medicine Services and Patient Visits Up 480% $WEED.ca $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 7:22 AM on Friday, April 17th, 2020

Empower Clinics closes private placement of $653,000.00 to support the Company growth plan and goes live with physician based immune boosting tele-medicine consultations with online professional supplement dispensing

  • Recently announced digital health initiative, has added physician based tele-medicine consultations to address immune system boosting requirements for existing patients and new patients, on a nationwide basis
  • The Company clinics have also seen a 480% increase in patient visits in the first half of April 2020

VANCOUVER, BC / April 17, 2020 / EMPOWER CLINICS INC. (CSE:CBDT)(Frankfurt:8EC)(OTCQB:EPWCF) (“Empower” or the “Company”), a vertically integrated life sciences company, is pleased to announce the closing of its non-brokered private placement of an aggregate of 16,325,000 units of the Company (each, a “Unit”) at a price of $0.04 per Unit for gross proceeds of $653,000.00 (the “Offering”).

The proceeds of the Offering are expected to be used by the Company for general working capital and corporate purposes.

The Company, as part of the recently announced digital health initiative, has added physician based tele-medicine consultations to address immune system boosting requirements for existing patients and new patients, on a nationwide basis. The Company clinics have also seen a 480% increase in patient visits in the first half of April 2020.

“Securing additional capital provides our Company more flexibility to support our staff and patients, during such a difficult time in history”, said Steven McAuley, Chairman & CEO. “We are hiring physicians and administrative staff right now to meet patient demand and adding technology resources to ensure our new services are available nationwide.”

In addition, our network of physicians will now be able to dispense over 250 premium supplement products to support patients’ needs, through a new online Sun Valley Health supplement store.

“Our new telemedicine platform is extremely robust, giving us the opportunity to provide a variety of modalities to our patients.” said Dustin Klein, Director and SVP Business Development. “We are focused on helping patients boost their immune systems and reduce stress and anxiety that may arise with isolation and social distancing.”

Each Unit is comprised of one Share and one Warrant, with each Warrant exercisable into one Warrant Share at an exercise price of $0.10 per Warrant Share for a period of two years following the Closing.

The Units, and the underlying Shares, Warrants and Warrant Shares (collectively, the “Securities”), are subject to restrictions on resale under applicable Canadian securities laws for a period of four months and one day from the closing of the Offerings. None of the Securities have been or will be registered under the United States Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements. This news release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of the securities, in any jurisdiction in which such offer, solicitation or sale would require registration or otherwise be unlawful.

ABOUT EMPOWER

Empower is a vertically integrated health & wellness company operating a network of physician-staffed wellness clinics, focused on helping patients improve and protect their health, through innovative physician recommended treatment options. The Company has its first hemp-derived CBD extraction facility under development, to produce proprietary lines of cannabidiol (CBD) based products to distribute through company owned and franchised clinics, wholesale partnerships, online channels and developing retail channels nationwide in the U.S.

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley
Chief Executive Officer

Investors: Dustin Klein
Director
dustin@svmmjcc,com
720-352-1398

Investors: Steven McAuley
CEO
[email protected]
604-789-2146

For French inquiries: Remy Scalabrini, Maricom Inc., E: [email protected], T: (888) 585-MARI

DISCLAIMER FOR FORWARD-LOOKING STATEMENTS

This news release contains certain “forward-looking statements” or “forward-looking information” (collectively “forward looking statements”) within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as “plans”, “continues”, “expects”, “projects”, “intends”, “believes”, “anticipates”, “estimates”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. Forward-looking statements in this news release include statements regarding; the Company’s intention to open a hemp-based CBD extraction facility, the expected benefits to the Company and its shareholders as a result of the proposed acquisitions and partnerships; the effectiveness of the extraction technology; the expected benefits for Empower’s patient base and customers; the benefits of CBD based products; the effect of the approval of the Farm Bill; the growth of the Company’s patient list and that the Company will be positioned to be a market-leading service provider for complex patient requirements in 2019 and beyond. Such statements are only projections, are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including; that the Company may not open a hemp-based CBD extraction facility; that legislative changes may have an adverse effect on the Company’s business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; general business, economic, competitive, political and social uncertainties; failure to obtain any necessary approvals in connection with the proposed acquisitions and partnerships; and other factors beyond the Company’s control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable laws.

Eyecarrot $EYC.ca Sports Vision Partnership with Eli Wilson Goaltending Redefines How 50,000 Aspiring Goalies See the Game

Posted by AGORACOM-JC at 7:17 AM on Friday, April 17th, 2020
Eyecarrot | LinkedIn
  • Announced a multi-year partnership with Eli Wilson Goaltending, a world leader in goaltending development, goaltending camps, and clinics
  • Eli Wilson has established himself as one of the premier goaltending coaches in the world through his work with dozens of goaltenders in the National Hockey League (NHL) and Team Canada

Toronto, New York -  April 17th, 2020 – Eyecarrot Innovations Corp., (Eyecarrot) (TSXV:EYC) | (OTC:EYCCF) | (2EYA:GR) is excited to announce a multi-year partnership with Eli Wilson Goaltending, a world leader in goaltending development, goaltending camps, and clinics. Eli Wilson has established himself as one of the premier goaltending coaches in the world through his work with dozens of goaltenders in the National Hockey League (NHL) and Team Canada. The partnership will provide Eli Wilson Goaltending camps with the Binovi Touch neurovision sports training hardware, alongside screen-based resources for athletes to support their development on and off the ice. The Eli Wilson Goaltending partnership will ultimately expose 600 active goaltending camp participants, aged 10 to 19 years and a global network of over 50,000 aspiring goaltending athletes to Eyecarrot’s Binovi Sport Vision Platform for off-ice training. As many nations continue to practice social distancing during COVID-19 and post pandemic, the Binovi Sports Vision Platform offers accessible turnkey athletic resources in step with subscription-based home fitness solutions Tonal, Peloton (PTON: NASDAQ) and Mirror. A subscription structure will support the company’s global product scaling strategy and “at-home” consumer offerings.

“I emphatically believe the best way to develop goaltenders is by teaching a system within a system. Quality drills, attention to detail, repetition and simplicity are major factors in building successful goaltenders. The goaltender must learn needed skills in a progressive manner in a controlled environment. With Binovi, we are gaining a sports vision training system to improve vision in that same controlled way, ensuring proper analysis and progress,” commented Eli Wilson, Eli Wilson Goaltending Founder, CEO

Under his tutelage, Eli’s camps –which see over 600 athletes annually– have produced more than 50 NHL draft picks, over 60 Division I, Canadian University goaltenders, and more than 200 players drafted by Major Junior teams. His goaltenders have gone on to win numerous prestigious awards and championships, including the Stanley Cup, Conn Smythe Trophy, Vezina Trophy, World Junior Gold Medals, American Hockey League (AHL) championships, AHL Playoff MVPs, Western Hockey League (WHL) Goaltender of the Year awards, Ontario Hockey League (OHL) Goaltender of the Year awards, and Canadian Hockey League (CHL) Goaltender of the Year awards. In addition to standard camp programming, Eli has introduced a number of specialty camps, including the popular 24/7 camp, where goaltenders actually live and train with Eli over a three-day weekend. A main staple of Eli’s year-round training is advanced video technology, whereby he and his staff can analyze video remotely to further goaltending development.

This strategic partnership will support Eyecarrot’s aggressive positioning of its sports vision performance offerings in the sport of hockey through an increased presence in key hockey development programs including direct NHL team alignments. Hockey, a leading sport in Canada, will benefit from big-tech partnerships of this nature that are designed to enhance athlete performance at all development levels of the sport.

“We’re very excited to be working with an athletic training team that clearly has a very high drive for success, and such an incredible track record for turning out exceptional players. Our goal is to see Binovi boost the performance of athletes going through these camps and training regimens. After all, competition is what drives sport, and any edge players and their training teams can get to get that competitive edge over an opponent is key. We look forward to working alongside Eli and his team as we continue to develop Binovi for sports,” stated Adam Cegielski, President and CEO.

Click here for more information on Binovi Sports Vision Training.

About Eli Wilson Goaltending

Eli Wilson has worked with over 30 NHL goalies (and counting) to sharpen all essential goaltending skills, including mental conditioning and off-ice training. Eli’s programs help to hone an athlete’s reflexes and improve agility in the net. The camp experience mirrors how Pro and NHL goaltenders’ practice, train, think, and act, to get to the top of their game. In 2004, Eli was named to Hockey Canada’s goaltending consultant group. He has consulted with Creative Artists Agency (CAA) Sports during their summer development camps for top young prospects in Los Angeles, California. Eli has also traveled to South Korea to work with the Kangwon Land Ice Hockey team and other young goaltenders in the country. From 2007 through 2010, Eli was the goaltending coach for the Ottawa Senators, where he was responsible for the Ottawa Senators goaltenders as well as for the goalies playing for their AHL affiliate, the Binghamton Senators. Established in 2010, the Eli Wilson Goaltending program sees over 600 athletes every year and helps give them the competitive edge to set themselves apart in a very challenging and exclusive club.

About the NHL

The National Hockey League (NHL(R)), founded in 1917, consists of 31 Member Clubs, each reflecting the League’s international makeup with players from more than 20 countries represented on team rosters, vying for the most cherished and historic trophy in professional sports – the Stanley Cup(R). Every year, the NHL entertains more than 670 million fans in-arena and through its partners on national television and radio; more than 151 million followers – league, team and player accounts combined – across Facebook, Twitter, Instagram, Snapchat and YouTube; and more than 100 million fans online at NHL.com. The League broadcasts games in more than 160 countries and territories through its rightsholders including NBC/NBCSN and the NHL Network(TM) in the U.S., Sportsnet and TVA in Canada, Viasat in the Nordic Region and CCTV and Tencent in China. The NHL reaches fans worldwide with games available online in every country including via its live and on-demand streaming service NHL.TV(TM). Fans are engaged across the League’s digital assets on mobile devices via the free NHL(R) App; across nine social media platforms; on SiriusXM NHL Network Radio(TM); and on NHL.com, available in eight languages and featuring unprecedented access to player and team statistics as well as every regular-season and playoff game box score dating back to the League’s inception, powered by SAP. The NHL is committed to building healthy and vibrant communities through the sport of hockey by increasing youth participation and engagement; fostering positive family experiences; promoting inclusion, positive culture and leadership; and supporting sustainable community impact.

About Eyecarrot Innovations Corp

Eyecarrot is a human performance technology company that has developed Binovi, a hardware and software-centered platform. Binovi combines hardware, software, specialized expert knowledge, and unique big data insights in order to deliver customized one-on-one training and treatment. Binovi is designed for vision optimization and the enhancement of cognitive skills related to human performance. We are working together under a common banner to help neuro-optometry, vision rehabilitation, and vision performance professionals gain measurable results in less time, and with less effort.

Adam Cegielski

President | CEO

Tania Archer

Head of Global Marketing | Sales | Strategic Partnerships

Investor Relations

Email: [email protected]

Toll-free: 1 (844) 866-6162

https://www.eyecarrot.com/investors/

Forward looking information:

Certain statements contained in this news release constitute “forward-looking information” as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company’s financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company’s financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company’s continuous disclosure filings filed under the Company’s profile at www.sedar.com . The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

NORTHBUD $NBUD.ca – Ontario online #pot orders hit high, keep steady amid coronavirus-related stockpiling $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 6:02 PM on Thursday, April 16th, 2020

SPONSOR: NORTHBUD (NBUD:CSE) Sustainable low cost, high quality cannabinoid production and procurement focusing on both bio-pharmaceutical development and Cannabinoid Infused Products. The company recently received Canadian Cultivation Licence for its Quebec Facility. Learn More.

Ontario online pot orders hit high, keep steady amid coronavirus-related stockpiling

  • Cannabis stockpiling in Ontario led to some heavy sales last month, and early signs show that the demand may be sticking around.
  • Data provided by the Ontario Cannabis Store showed daily online orders hovered in the mid-2,000 range for the first half of last month, tripling when Canada moved to restrict U.S. border access and spiking to a high of nearly 14,000 when Ontario announced pot shops would be a non-essential business, requiring their temporary closure.

Ontario online pot orders hit high, keep steady amid coronavirus-related stockpiling 

Cannabis stockpiling in Ontario led to some heavy sales last month, and early signs show that the demand may be sticking around. Data provided by the Ontario Cannabis Store showed daily online orders hovered in the mid-2,000 range for the first half of last month, tripling when Canada moved to restrict U.S. border access and spiking to a high of nearly 14,000 when Ontario announced pot shops would be a non-essential business, requiring their temporary closure. Two weeks later, daily sales have held steady around the 9,000 level, almost five times the amount made prior to the start of the pandemic. While it may be too early to really gauge how COVID-19 will impact legal cannabis sales over the long term, the OCS numbers provide a highly precise glimpse at how people are consuming cannabis during the pandemic.

Source: links.mkt2011.com/servlet/MailView?ms=MzIxMzM4MzQS1&r=MjU5OTkyNTIyMjg1S0&j=MTY4MzcwMDAwMwS2&mt=1&rt=0

PyroGenesis $PYR.ca Confirms Additional Payment of $1.4M Towards $25M+ DROSRITE™ Contract $RTN $NOC $UTX $HPQ.ca $DDD.ca $SSYS $PRLB

Posted by AGORACOM-JC at 1:52 PM on Thursday, April 16th, 2020
  • Announced that further to its press release dated March 24th, 2020, the second payment of approx. $1.4M has already been received under the exclusive contract with Drosrite International LLC
  • “Due to an unprecedented number of inquiries received from investors, we decided to confirm receipt of the second payment of $1.4M noted in this press release,” said Mr. P. Peter Pascali, President and CEO of PyroGenesis

MONTREAL, April 16, 2020 — PyroGenesis Canada Inc. (http://www.pyrogenesis.com) (TSX-V: PYR) (OTCQB: PYRNF) (FRA: 8PY), a high-tech company, (the “Company”, the “Corporation” or “PyroGenesis”) that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch products, in response to an extraordinary volume of inquiries with respect to the subject matter, is pleased to announce that, further to its press release dated March 24th, 2020, the second payment of approx. $1.4M has already been received under the exclusive contract with Drosrite International LLC (“DI”).

“Due to an unprecedented number of inquiries received from investors, we decided to confirm receipt of the second payment of $1.4M noted in this press release,” said Mr. P. Peter Pascali, President and CEO of PyroGenesis. “We would also like to confirm that additional payments are being processed as anticipated and that, as per DI’s press release dated January 27th, 2020, work has already begun. I would also like to take this opportunity to further emphasize to readers that in general, notwithstanding receipt of payments, revenues and expenses are based on percent completion and not receipt of payments.”

As previously disclosed, and as part of this exclusive arrangement between DI and PyroGenesis, DI will pay PyroGenesis approximately $25M, based on current exchange rates, over the first 12 months as well as approx. $3M per year (fixed) for the next two (2) years, together with a variable amount for the subsequent 18 years based on certain international benchmarks.

About Drosrite International LLC

DI is a US based private company duly constituted and existing under the laws of the State of Delaware, providing state-of-the-art waste management technologies to the aluminum industry. DI is duly licensed by PyroGenesis to manufacture, market, sell and distribute DROSRITE™ systems and technology to the Kingdom of Saudi Arabia, and certain other countries in the Middle East, on an exclusive basis. All DROSRITE™ systems supplied by DI are manufactured in the USA.

About PyroGenesis Canada Inc.

PyroGenesis Canada Inc., a high-tech company, is the world leader in the design, development, manufacture and commercialization of advanced plasma processes and products. We provide engineering and manufacturing expertise, cutting-edge contract research, as well as turnkey process equipment packages to the defense, metallurgical, mining, advanced materials (including 3D printing), oil & gas, and environmental industries. With a team of experienced engineers, scientists and technicians working out of our Montreal office and our 3,800 m2 manufacturing facility, PyroGenesis maintains its competitive advantage by remaining at the forefront of technology development and commercialization. Our core competencies allow PyroGenesis to lead the way in providing innovative plasma torches, plasma waste processes, high-temperature metallurgical processes, and engineering services to the global marketplace. Our operations are ISO 9001:2015 and AS9100D certified, and have been since 1997. PyroGenesis is a publicly-traded Canadian Corporation on the TSX Venture Exchange (Ticker Symbol: PYR) and on the OTCQB Marketplace. For more information, please visit www.pyrogenesis.com

This press release contains certain forward-looking statements, including, without limitation, statements containing the words “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect”, “in the process” and other similar expressions which constitute “forward- looking information” within the meaning of applicable securities laws. Forward-looking statements reflect the Corporation’s current expectation and assumptions and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those anticipated. These forward-looking statements involve risks and uncertainties including, but not limited to, our expectations regarding the acceptance of our products by the market, our strategy to develop new products and enhance the capabilities of existing products, our strategy with respect to research and development, the impact of competitive products and pricing, new product development, and uncertainties related to the regulatory approval process. Such statements reflect the current views of the Corporation with respect to future events and are subject to certain risks and uncertainties and other risks detailed from time-to-time in the Corporation’s ongoing filings with the securities regulatory authorities, which filings can be found at www.sedar.com, or at www.otcmarkets.com. Actual results, events, and performance may differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. The Corporation undertakes no obligation to publicly update or revise any forward- looking statements either as a result of new information, future events or otherwise, except as required by applicable securities laws. Neither the TSX Venture Exchange, its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) nor the OTCQB accepts responsibility for the adequacy or accuracy of this press release.

SOURCE PyroGenesis Canada Inc.

For further information please contact:

Rodayna Kafal, Vice President Investors Relations and Strategic Business Development,
Phone: (514) 937-0002, E-mail: [email protected]

RELATED LINK: http://www.pyrogenesis.com/

Esports Entertainment Group $GMBL Announces Closing of Above Market $8.4 Million Public Offering and Uplisting to Nasdaq $TECHF $ATVI $TTWO $GAME $EPY.ca $FDM.ca $TNA.ca

Posted by AGORACOM-JC at 1:06 PM on Thursday, April 16th, 2020
  • Common stock and Unit A Warrants began trading on the Nasdaq Capital Market on April 14, 2020, under the symbols “GMBL” and “GMBLW,” respectively
  • Company received gross proceeds of approximately $8.4 million, before deducting underwriting discounts and commissions and other estimated offering expenses

BIRKIRKARA, Malta, April 16, 2020 — Esports Entertainment Group, Inc. (NasdaqCM: GMBL, GMBLW) (or the “Company”) a licensed online gambling company with a focus on esports wagering and 18+ gaming, today announced the closing of its previously announced underwritten public offering of 1,980,000 units at a price to the public of $4.25 per unit. Each unit issued in the offering consists of one share of common stock, one Unit A Warrant to purchase one share of common stock and one Unit B Warrant to purchase one share of common stock. The common stock, Unit A Warrants and Unit B Warrants were immediately separable from the units and were issued separately. The common stock and Unit A Warrants began trading on the Nasdaq Capital Market on April 14, 2020, under the symbols “GMBL” and “GMBLW,” respectively. Esports Entertainment Group received gross proceeds of approximately $8.4 million, before deducting underwriting discounts and commissions and other estimated offering expenses.

Each Unit A Warrant is immediately exercisable for one share of common stock at an exercise price of $4.25 per share and will expire 5 years from issuance, and each Unit B Warrant is immediately exercisable at an exercise price of $4.25 per share and will expire one year from issuance. 

Esports Entertainment Group has granted the underwriters a 45-day option to purchase up to 297,000 additional shares of common stock, and/or 297,000 Unit A Warrants, and/or 297,000 Unit B Warrants, or any combination thereof, to cover over-allotments, if any. On April 16, 2020, the Company issued additional Unit A Warrants to purchase 209,400 shares of the Company’s common stock and additional Unit B Warrants to purchase 209,400 shares of the Company’s common stock pursuant to the partial exercise  of the underwriters’ over-allotment option in connection with the offering.

Maxim Group LLC acted as the lead book-running manager for the offering. Joseph Gunnar & Co., LLC acted as co-book-running-manager for the offering.

The offering was conducted pursuant to the Company’s registration statement on Form S-1 (File No. 333-231167) previously filed with and subsequently declared effective by the Securities and Exchange Commission (“SEC”).  A prospectus relating to the offering will be filed with the SEC and will be available on the SEC’s website at http://www.sec.gov.  Electronic copies of the prospectus relating to this offering, when available, may be obtained from Maxim Group LLC, 405 Lexington Avenue, 2nd Floor, New York, NY 10174, at (212) 895-3745.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

ABOUT ESPORTS ENTERTAINMENT GROUP

Esports Entertainment Group, Inc. is a licensed online gambling company with a specific focus on esports wagering and 18+ gaming. Esports Entertainment offers fantasy, pools, fixed odds and exchange style wagering on esports events in a licensed, regulated and secure platform to the global esports audience at vie.gg.  In addition, Esports Entertainment intends to offer users from around the world the ability to participate in multi-player mobile and PC video game tournaments for cash prizes. Esports Entertainment is led by a team of industry professionals and technical experts from the online gambling and the video game industries, and esports. The Company holds a license to conduct online gambling and 18+ gaming on a global basis in Curacao, Kingdom of the Netherlands. The Company maintains offices in Malta. For more information visit www.esportsentertainmentgroup.com

FORWARD-LOOKING STATEMENTS

The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The safe harbor for forward-looking statements contained in the Securities Litigation Reform Act of 1995 protects companies from liability for their forward-looking statements if they comply with the requirements of the Act.

Contact:

U.S. Investor Relations 
RedChip Companies, Inc.
Dave Gentry
407-491-4498
[email protected]

Media & Investor Relations Inquiries
AGORACOM
[email protected] 
http://agoracom.com/ir/eSportsEntertainmentGroup

Datametrex $DM.ca Obtains Rights to Import and Sell COVID-19 Test Kits From South Korea

Posted by AGORACOM-JC at 7:15 AM on Thursday, April 16th, 2020
  • Entered into an agreement on April 13, 2020 securing the rights to import the iONEBIO INC’s iLAMP Novel-CoV19 Detection Kit (real-time Reverse Transcription LAMP-PCR assay system) into Canada
  • Under the terms of this agreement, Datametrex was also given rights to sell the tests into other countries around the globe, including the United States
  • iONEBIO Inc. claims their test kits provide results within approximately 15 to 20 minutes with 99.9% accuracy

TORONTO, April 16, 2020  — Datametrex AI Limited (the “Company” or “Datametrex”) is pleased to announce that entered into an agreement on April 13, 2020 securing the rights to import the iONEBIO INC’s iLAMP Novel-CoV19 Detection Kit (real-time Reverse Transcription LAMP-PCR assay system) into Canada, Under the terms of this agreement, Datametrex was also given rights to sell the tests into other countries around the globe, including the United States. Datametrex has developed strong relationships with many large multi-national companies in South Korea.  As a result of these relationships, the Canadian Embassy in Seoul contacted Datametrex to ask for help in procuring rapid test kits.

The COVID-19 test kits are manufactured by iONEBIO INC. in South Korea, and are the same test kits that have been successfully used in South Korea in their “drive-through” testing stations. This kit has also been used to test every traveller entering into South Korea and those testing positive for Covid-19 were immediately isolated.  Datametrex believes a key factor that allowed South Korea to slow the spread of COVID-19 was its ability to swiftly identify and quarantine those infected by testing millions of people using these test kits  These test kits were first approved for use by the Korean Ministry of Food and Drug Safety on August 30, 2019.  In addition, an independent study was conducted by DankukUniversity (DKU) in Seoul, South Korea, and it was completed and approved on April 2, 2020.

Health Canada must approve these COVID-19 test kits before they can be used in Canada. The Company is currently working with Health Canada to have the approval of these kits fast tracked.  These test kits are currently in use in some European and Asian countries outside of South Korea. Approval work has commenced with the FDA in the United States to obtain FDA approval and to authorize the tests under the Emergency Use Authorization Program run by US Center for Disease Control (CDC).

iONEBIO Inc. claims their test kits provide results within approximately 15 to 20 minutes with 99.9% accuracy. Each kit contains 288 individual tests, all of which can be completed in one hour. By utilizing these kits, screening stations can be set up almost anywhere and will allow for the early detection and swift quarantine of infected persons, which is believed to be a key factor in slowing the spread of the novel coronavirus.  Early detection using rapid tests will also provide further protection to Canada’s front-line workers, especially health care professionals.

South Korea has used this kit to test millions of its citizens and, as of April 14, 2020, there have been 10,654 cases of Covid-19 and 222 deaths reported. In North America, where the use of a rapid test has not been implemented on a large scale, there have been, as at April 14, 2020, 25,680 cases and 780 deaths in Canada and 588,465 cases and 23,711 death in the US.  (All data collected by Datametrex’s Covid-19 dashboard, which is available at http://www.datametrex.com/covid-board.html)

“We strongly believe these kits will assist Canada in slowing the spread of Covid-19 and ultimately save lives. It’s incredibly rewarding for us to be able to help Canada combat the spread of COVID-19,” said Andrew Ryu, Chairman of the Company.

If the test kits are approved by Health Canada and the Canadian government purchases these test kits as expected, the Canadian government will be required to pay the kits in advance. Datametrex expects that all of its costs and expenses related to the import of these tests will be satisfied out of the purchase price for the tests paid for by the Canadian government.

The Company is not making any express or implied claims that it has the ability to treat the Covid-19 virus at this time.

About Datametrex AI Limited

Datametrex AI Limited is a technology-focused company with exposure to Artificial Intelligence and Machine Learning through its wholly-owned subsidiary, Nexalogy (www.nexalogy.com).
Additional information on Datametrex is available at www.datametrex.com

For further information, please contact:

Marshall Gunter – CEO
Phone: (514) 295-2300
Email: [email protected]

Jeff Stevens- Co-Founder
Phone: (647) 400-8494
Email: [email protected]

Neither the TSX Venture Exchange nor it’s Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This news release contains “forward-looking information” within the meaning of applicable securities laws.  All statements contained herein that are not clearly historical in nature may constitute forward-looking information. In some cases, forward-looking information can be identified by words or phrases such as “may”, “will”, “expect”, “likely”, “should”, “would”, “plan”, “anticipate”, “intend”, “potential”, “proposed”, “estimate”, “believe” or the negative of these terms, or other similar words, expressions and grammatical variations thereof, or statements that certain events or conditions “may” or “will” happen, or by discussions of strategy.

Readers are cautioned to consider these and other factors, uncertainties and potential events carefully and not to put undue reliance on forward-looking information. The forward-looking information contained herein is made as of the date of this press release and is based on the beliefs, estimates, expectations, and opinions of management on the date such forward-looking information is made. The Company undertakes no obligation to update or revise any forward-looking information, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.

North Bud Farms Fuels California Growth $CGC $ACB $APH $CRON.ca $OGI.ca

Posted by AGORACOM-JC at 6:23 PM on Wednesday, April 15th, 2020
  • Fueled its California growth with the execution of definitive agreements for a master lease, operations and royalty arrangement with an experienced California-licensed operator
  • To operate the licensed facilities at the Company’s Salinas, California farm
  • Significantly strengthens the Company’s facility operations while allowing the Company to increase its asset value

TORONTO, April 15, 2020 — North Bud Farms Inc. (CSE: NBUD) (OTCQB: NOBDF) (“NORTHBUD” or the “Company“) is pleased to announce that its U.S. subsidiary, Bonfire Brands USA Inc., has fueled its California growth with the execution of definitive agreements (the “Agreements”) for a master lease, operations and royalty arrangement with an experienced California-licensed operator (the “Cultivator”), to operate the licensed facilities at the Company’s Salinas, California farm.

Highlights of the California Deal

  • Partnering with a proven licensed cannabis cultivator who has been operating successfully in Salinas for several years;
  • Significantly strengthens the Company’s facility operations while allowing the Company to increase its asset value;
  • Reduces the Company’s capital expenditure requirements while still generating significant revenue and retaining a portion of the unlimited upside potential through a royalty agreement;
  • Builds EBITDA-positive operations; and
  • Access to a cost-efficient and reliable supply chain on which to build the Company’s branded product portfolio within the state of California.

Terms of the Agreement
As per the terms of the Agreements, the Cultivator will lease the Company’s Salinas farm for 5 years, with options to extend the lease for up to an additional 5 years, and Bonfire Brands USA Inc. will receive the following consideration:

  • Lease payments of USD$900,000 per year, with incremental increases if the Cultivator extends the lease beyond the initial 5 year term;
  • A royalty equal to 5% of the gross revenue generated by the Cultivator from its use of the Salinas farm; and
  • The right to acquire a significant portion of the product harvested each quarter on the farm by the Cultivator, at a 15% discount to market rate.

During the term of the Agreements, the Cultivator will be responsible for the costs of operating the farm, including but not limited to staffing, operations, repair, maintenance, licensing and compliance; moreover, the Cultivator is committed to funding and managing the build-out of up to an additional 230,000 sq. ft. of licensed cultivation space in order to maximize the revenue-generating potential of the property.

“We are very pleased to have concluded this deal as we partner with an established operator to build up our asset and to secure access to high-quality, low-cost cannabis,” said Justin Braune, President of Bonfire Brands USA. “This deal will allow the Company to immediately achieve EBITDA-positive operations at our largest facility without incurring significant capital investments. By retaining preferential purchasing terms, the Company can now focus on the success of its branded product lines, on the back of the estimated 40,000 pounds of production capacity that the Cultivator is expected to bring online over the next 24 months.”

About North Bud Farms Inc.
NORTHBUD owns and operates, through its subsidiaries, licensed cannabis facilities in Canada, California and Nevada. Bonfire Brands USA, the Company’s U.S. subsidiary, acquired cannabis production facilities in Salinas, California and Reno, Nevada in late 2019. The Salinas, California 11-acre farm is actively cultivating cannabis in its 60,000 sq. ft. of licensed greenhouse production space. The Reno, Nevada facility, located on 3.2 acres of land, was acquired through the acquisition of Nevada Botanical Science, Inc., and includes a world-class cannabis production, research and development facility with 5,000 sq. ft. of indoor cultivation space which holds medical and adult-use licenses for cultivation, extraction and distribution. Through its wholly-owned Canadian subsidiary, GrowPros MMP Inc., the Company built and owns a state-of-the-art purpose-built cannabis production facility located on 135 acres of agricultural land in Low, Quebec, Canada. The Low, Quebec facility currently has 24,500 sq. ft. of licensed indoor cultivation space; the Company expects to submit its licence application to Health Canada for an additional 1,000,000 sq. ft. of outdoor cultivation space in the near future.

For more information visit: www.northbud.com

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements
Certain statements and information included in this press release that, to the extent they are not historical fact, constitute forward-looking information or statements (collectively, “forward-looking statements”) within the meaning of applicable securities legislation. Forward-looking statements, include but are not limited to those identified by the expressions “anticipate”, “believe”, “plan”, “estimate”, “expect”, “intend”, “may”, “should” and similar expressions to the extent they relate to the Company or its management.

Forward-looking statements, including but not limited to, the success of its arrangement with the Cultivator to lease and operate its Salinas farm, U.S. and Canadian strategies, the success of the Company’s licence application with Health Canada, the Company’s ability to execute its strategic plan, conditions in the cannabis market, the Company entering agreements in connection with the B2B supply of cannabis and the Company’s transition into a revenue-generating operational phase of development are based on the reasonable assumptions, estimates, analysis and opinions of management made in light of its experience and its perception of trends, current conditions and expected developments, as well as other factors that management believes to be relevant and reasonable in the circumstances at the date that such statements are made, but which may prove to be incorrect.

Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements expressed or implied by the forward-looking statements. Such risks and uncertainties include, among others, the risk factors included in the Company’s final long form prospectus dated August 21, 2018, which is available under the Company’s SEDAR profile at www.sedar.com. Accordingly, readers should not place undue reliance on any such forward-looking statements. Further, any forward-looking statement speaks only as of the date on which such statement is made. New factors emerge from time to time, and it is not possible for the Company’s management to predict all of such factors and to assess in advance the impact of each such factor on the Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. The Company does not undertake any obligation to update any forward-looking statements to reflect information, events, results, circumstances or otherwise after the date hereof or to reflect the occurrence of unanticipated events, except as required by law including securities laws. This news release does not constitute an offer to sell or a solicitation of any offer to buy any securities of the Company.

FOR ADDITIONAL INFORMATION, PLEASE CONTACT:
North Bud Farms Inc.
Edward Miller
VP, IR & Communications
Office: (855) 628-3420 ext. 3
[email protected]